Women were less than half of the people tested for almost all of these common medicines.
PregnancyCommunity forum

NCT01556997

Perindopril Amlodipine for the Treatment of Hypertension

See it on ClinicalTrials.gov ↗

837 people

407 womenmiddle line = equal numbers430 men
Phase
PHASE3
Paid for by
Symplmed Pharmaceuticals LLC
Finished
2013-02
Health conditions
Essential Hypertension
Who could join
Anyone
Ages
18 Years – 75 Years
Average age
Not reported
Age 65+
7.2%
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
Black / African American 67.1% · White 32.3% · Asian 0.2% · Native Hawaiian / Pacific Islander 0.2% · Not reported 0.1% · American Indian / Alaska Native 0% · More than one race 0%

Women left out

  • No pregnant women

    Women who were pregnant could not join.

    “Female subjects who are pregnant, planning to become pregnant”
  • No kidney or liver problems

    Women with kidney or liver problems were turned away.

    “Renal dysfunction, severe renal impairment, bilateral renal artery stenosis, renal artery stenosis in a solitary kidney, subjects with only 1 kidney, or post-renal transplant subjects”
  • No heart disease

    Women with heart disease, heart rhythm problems or a past heart attack were turned away.

    “Heart failure (NYHA functional class 3-4), hypertrophic obstructive cardiomyopathy, or hemodynamically relevant stenosis of the aortic or mitral valve”
  • No cancer

    Women with current or past cancer were turned away.

    “History of malignancy within 5 years”

Study titles and rules are shown in their original English.